These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1175 related items for PubMed ID: 20586932

  • 41. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
    Liu Y, Cheng LS, Wu SD, Wang SQ, Li L, She WM, Li J, Wang JY, Jiang W.
    Clin Sci (Lond); 2016 Jun 01; 130(11):907-19. PubMed ID: 26980345
    [Abstract] [Full Text] [Related]

  • 42. Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients.
    Stoop JN, Claassen MA, Woltman AM, Binda RS, Kuipers EJ, Janssen HL, van der Molen RG, Boonstra A.
    Clin Immunol; 2008 Dec 01; 129(3):419-27. PubMed ID: 18823821
    [Abstract] [Full Text] [Related]

  • 43. Antigen-induced regulatory T cells in HBV chronically infected patients.
    Barboza L, Salmen S, Goncalves L, Colmenares M, Peterson D, Montes H, Cartagirone R, Gutiérrez Mdel C, Berrueta L.
    Virology; 2007 Nov 10; 368(1):41-9. PubMed ID: 17643462
    [Abstract] [Full Text] [Related]

  • 44. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.
    Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG, Janssen HL.
    Hepatology; 2005 Apr 10; 41(4):771-8. PubMed ID: 15791617
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.
    Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, Zhao JM, Zhang B, Shi M, Ding X, Tang Z, Fu YX, Wang FS.
    J Immunol; 2006 Jul 01; 177(1):739-47. PubMed ID: 16785573
    [Abstract] [Full Text] [Related]

  • 52. [Clinical significance of regulatory T cells proportion in the peripheral blood and tumor tissue in primary hepatocellular carcinoma].
    Li SP, Peng QQ, Ding T, Xu J, Zhang CQ, Feng KT, Li JQ.
    Zhonghua Zhong Liu Za Zhi; 2008 Jul 01; 30(7):523-7. PubMed ID: 19062720
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Immune Regulation by T Regulatory Cells in Hepatitis B Virus-Related Inflammation and Cancer.
    Trehanpati N, Vyas AK.
    Scand J Immunol; 2017 Mar 01; 85(3):175-181. PubMed ID: 28109025
    [Abstract] [Full Text] [Related]

  • 58. Study of liver-targeted regulatory T cells in hepatitis B and C virus in chronically infected patients.
    Miyaaki H, Zhou H, Ichikawa T, Nakao K, Shibata H, Takeshita S, Akiyama M, Ozawa E, Miuma S, Eguchi K.
    Liver Int; 2009 May 01; 29(5):702-7. PubMed ID: 18673437
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A, Noble A.
    J Leukoc Biol; 2007 Nov 01; 82(5):1053-61. PubMed ID: 17684039
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.